- Texas-based Neutra Corp. produces nutraceutical vapor products and is expanding into hemp cultivation and purified hemp extract products
- The wellness product industry measures in the trillions of dollars, growing faster than the global economy, and the hemp cultivation industry is expected to top $26 billion by 2025
- The LOI for Vivis would grant Neutra Corp. an established brand of products built on crystalline CBD and full-spectrum CBD extract, while the J3 Holdings LOI would deliver land, a warehouse and a license to cultivate and refine hemp
The growing focus on health and wellness products and philosophies during recent decades has created a bustling marketplace in which businesses and consumers work collaboratively on wallet-friendly ways to love life in the living of it. Neutra Corp. (OTCQB: NTRR) is an interested player in the arena, advancing its interests in monetizing early stage research and development efforts to build a better human body and global environment by growing vertically within the nutraceuticals, food and drug, and environmental purification sectors.
Neutra Corp. has recently pursued the acquisition of companies that hold licenses to cultivate and process hemp, and to sell established high quality, high potency hemp-extracted products, through letters of intent that would bring the subsidiaries’ strengths into the fold.
The Global Wellness Institute reported last fall that the wellness industry grew by 6.4 percent each year from 2015 to 2017, topping $4.2 trillion as a market growing nearly twice as fast as the global economy (http://ibn.fm/FyvcI) as a result of concerns over the rising costs of health care and growing reporting of select chronic ailments among younger-than-traditional populations. The global hemp industry is expected to experience a CAGR of 34 percent from now to 2025, according to Research and Markets analysts, growing from $4.6 billion to $26.6 billion (http://ibn.fm/yEW8k).
Neutra Corp.’s efforts to develop its portfolio demonstrate its recognition of the market factors in play, as well as its conscientiousness in making a quality of life difference for people. Medical-grade hemp extracts have gained a reputation for helping people to manage pain and anxiety, whether from chronic diseases, athletic injuries or everyday aches and pains.
The company has entered two LOIs for emerging hemp retail brand Vivis and hemp cultivator J3 Holdings. The Vivis acquisition “will give Neutra Corp. an even stronger market presence with an established brand already recognized for superiority,” Neutra Corp. President and CEO Sydney Jim stated in a news release (http://ibn.fm/vtDdG).
Vivis has a product line that uses a 99 percent or higher grade of hemp-extracted crystalline CBD, and the firm is preparing to launch a second brand with an 80 percent or higher grade of full-spectrum CBD extract. Vivis’ extracts are certified by a third-party lab to ensure their quality.
J3 Holdings has land, a warehouse and a license to cultivate and refine hemp that are expected to prove valuable additions to Neutra Corp.’s stable.
For more information, visit the company’s website at www.NeutraInc.com
NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://ibn.fm/NTRR
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
